Delivery Order SPE2DB20D9335-SPE2DB25FW3V6
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $7.4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,410.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This firm fixed-price delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and carries no set-aside designation. The contract is performed at the vendor's facility in Park Ridge, Illinois. This delivery order is...
- This federal contract award is a delivery order valued at $11,263.20 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, with a completion date of December 20, 2024. The award is not associated with a set-aside designation and is a firm fixed-price delivery order. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,544.60 for Typhoid VI Polysaccharide vaccine on July 23, 2025, with an ultimate completion date of August 4, 2025. This delivery order was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award represents a continuation of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,220,848 units of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. The $1,748.69 delivery order was issued under DMS Pharmaceutical's $4,999,999 indefinite delivery vehicle (IDV) contract SPE2DB with DLA to supply a broad range of pharmaceutical items to U.S. military medical facilities worldwide. This contract award does not...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,705.00 to DMS Pharmaceutical Group Inc. for TYPHIM VI 25 MCG/0.5 ML syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid fever, making this delivery order a critical component of the Department of Defense's medical supply chain. The contract carries no set-aside designation, and performance is scheduled at DMS...
- This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,040.42 contract is for the supply of 4565900982 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $48,899.74 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
- This federal contract award is a delivery order valued at $1,900.75 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of a typhoid vaccine, with a ceiling value of $9,363.78 and a period of performance through May 22, 2024. The contract is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, known as the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand sixty-nine dollars by the Defense Logistics Agency Troop Support Medical to provide eight hundred fifty thousand eight hundred four vials of typhoid vaccine. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical products with a potential value of up to five million dollars...